Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01909180 · ClinicalTrials.gov registry record · NA
Clinical Evaluation for General Electric (GE) CT System
A NA study of CT Scanners X Ray, sponsored by GE Healthcare.
- Completed
- Registry status
- NA
- Development phase
- 49
- Enrollment target
- 1
- Study location
NCT01909180: Completed NA study of CT Scanners X Ray, sponsored by GE Healthcare.
NCT01909180 is a NA study of CT Scanners X Ray that has completed, run by GE Healthcare. The registered enrollment target is 49 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01909180, a NA study of CT Scanners X Ray, has completed, sponsored by GE Healthcare.
- COMPLETED
- Registry status
- NA
- Development phase
- 49 participants
- Enrollment target
- 1
- Study location
Study Summary
An external evaluation to obtain clinical data to create sample clinical images. The data will also be used for product and technology development, marketing materials, and inclusion in publications.
Primary Outcome
Image quality assessment on a 5 point Likert Scale: 5= Diagnostic- Excellent Image Quality 4= Diagnostic- Good Image Quality 3= Diagnostic-Acceptable Image Quality 2= Sub-Optimal Diagnostic with limited additional clinical information 1= Non-Diagnostic
Conditions Studied
Interventions
- DEVICE Revolution CT Scanner
Study Locations (1)
Florida
- Baptist South Florida Hospital - Miami
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 49 participants |
| Start Date | 2013-05 |
| Est. Completion | 2013-12 |
| Phase | NA |
What the finished NCT01909180 record still lists
NCT01909180 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 49 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).
The record links to 1 condition, with CT Scanners X Ray appearing as the primary indexed condition, and to 1 intervention - of which Revolution CT Scanner is the first listed.
NCT01909180 reports a single indexed study location in Florida.
Frequently Asked Questions
What is clinical trial NCT01909180 about?
NCT01909180 is a clinical study titled "Clinical Evaluation for General Electric (GE) CT System". An external evaluation to obtain clinical data to create sample clinical images. The data will also be used for product and technology development, marketing materials, and inclusion in publications.
What is the current status of trial NCT01909180?
This trial is currently completed. It is a NA study. The enrollment target is 49 participants. The study started on 2013-05. Estimated completion is 2013-12.
What conditions does trial NCT01909180 study?
This clinical trial studies the following conditions: CT Scanners X Ray.
What interventions are being tested in trial NCT01909180?
The interventions under investigation include: Revolution CT Scanner (DEVICE).
Who is sponsoring clinical trial NCT01909180?
This trial is sponsored by GE Healthcare, which has 99 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01909180 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01909180's enrollment target sits among peer trials
49 1379th of 2000 higher than 620 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02704858 · 49 participants · Phase 1
Safety and Efficacy Study in Recurrent or Progressive Grade III or IV IDH1 Mutated Glioma
- NCT03516708 · 49 participants · Phase 1
Epacadostat (INCB024360) Added to Preoperative Chemoradiation in Patients With Locally Advanced Rectal Cancer
- NCT03692429 · 49 participants · Phase 1
alloSHRINK - Standard cHemotherapy Regimen and Immunotherapy With Allogeneic NKG2D-based CYAD-101 Chimeric Antigen Receptor T-cells
- NCT04329494 · 49 participants · Phase 1
PIPAC for the Treatment of Peritoneal Carcinomatosis in Patients With Ovarian, Uterine, Appendiceal, Colorectal, or Gastric Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia